Skip to Main Content

An official website of the United States government

View 0 Studies Requested

Trial Summary

About CDAS Project, PI, Publications: Translating gene-calcium interactions to precision medicine for colorectal cancer

Datasets


Site: Colon

Inclusion Criteria:

  • No Rare Cancers
  • No Prior History of Any Cancer
  • No Specified Colon Comorbidities
  • No Colorectal Cancers as non-first Diagnoses
  • No T0 Adenomas in Colo/Inci. Aden. Controls
  • With Pre-Exit Serum

Matching Factors:

  • Gender
  • Age at Randomization (5 year intervals)
  • Race (3 levels)
  • Geographic Region (latitudinal)
  • Study Year of Draw + Calendar Year of Draw
  • Month of Draw
  • Time of Day of Draw (am/pm)

Match Ratio: 1:1

Match Technique: Frequency matching only non-cases as controls.

Additional Matching Comments: Year/month/time of draw were loosened, as needed, to complete matching. No matching was performed for recurrent adenoma cases.


Analytes:

  • 25-Hydroxyvitamin D
  • N-TACT Parathyroid Hormone

Number of Cases: 750 colorectal; 753 incident adenoma; 755 recurrent adenoma

Number of Controls: 751 colorectal; 755 incident adenoma; 755 recurrent adenoma